05/21/2026
Join Dr. Jerry Dreessen live today at 1:30 PM ET — PEMF Is Moving Beyond "Cellular Support": Here's What the Research Is Showing Now
For years, PEMF conversations relied on broad language — cellular support, circulation, inflammation, recovery. The newer research is asking much more specific questions: What cellular pathways are involved? What parameters matter? Which conditions show stronger evidence? And how do we talk about all of this without overstating what the science can actually support?
In this session we cover:
• The shift from broad claims to specific pathway research
• Mitochondria, ATP synthesis, and what the 2026 data is showing
• Better inflammation language using NF-κB and MAPK pathway research
• Pain evidence — a 36% reduction RCT and why parameters matter
• The neuropathic pain protocol problem
• Magnetic mitohormesis and metabolic research (what to say — and what NOT to say)
• Sarcopenia, aging-related muscle function, and supportive care
• Parkinson's and neurological research — promising but preliminary
• Oncology support — the highest-caution category
• Documentation, professional standards, and practitioner takeaways
If you want to operate more clearly, confidently, and responsibly in today's PEMF landscape, this is a foundational update you don't want to miss.
� Studies Referenced in Today's Session:
Here are the studies mentioned in today’s live:
PEMF and mitochondria — Scientific Reports, 2026�Interaction of pulsed low frequency electromagnetic field PEMF with mitochondria. (Nature)
PEMF for joint and soft tissue pain — randomized clinical trial, 2025�Evaluating Noninvasive Pulsed Electromagnetic Field Therapy for Joint and Soft Tissue Pain Management. (PMC)
PEMF and neuropathic pain — systematic review and meta-analysis, 2026�Effectiveness of Pulsed Electromagnetic Field Therapy on Neuropathic Pain. (PMC)
PEMF and inflammation — Bioengineering review, 2025�Regulation of Inflammatory Responses by Pulsed Electromagnetic Fields. (PubMed)
Magnetic mitohormesis and Type 2 diabetes — exploratory study, 2025�Investigating the Metabolic Benefits of Magnetic Mitohormesis in Patients with Type 2 Diabetes Mellitus. (PMC)
PEMF and sarcopenia in elderly adults — 2025�The Effects of Pulsed Electromagnetic Field on Muscular Strength, Functional Performance and Depressive Symptoms in Elderly Adults with Sarcopenia. (PMC)
T-PEMF and Parkinson’s tremor — Clinical Biomechanics, 2026�Effects of long-term treatment with transcranial pulsed electromagnetic fields in Parkinson’s disease on kinematic and electrophysiological tremor. (PubMed)
PEMF and acute radiodermatitis in breast cancer patients — randomized controlled study, 2026�Efficacy of pulsed electromagnetic field therapy on acute radiodermatitis in breast cancer patients. (PMC)
� Learn more: https://pemfprofessionals.com
� Questions? Reach out through the AOPP community